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Abstract
Purpose The purpose of the present study was to determine the relationship between infertility and the polymorphisms of
mitochondrial NADH dehydrogenase subunit 4 (MTND4) by spermatozoa analysis in fertile and subfertile men.
Methods Samples were divided into 68 subfertile men (case group) and 44 fertile men (control group). After semen analysis,
samples were purified. The whole genome was extracted using a QIAamp DNA Mini Kit and the mitochondrial DNA was
amplified by using the REPLI-g Mitochondrial DNA Kit. Polymerase chain reaction (PCR) was used to amplify the MT-ND4
gene. Then, samples were purified and sequenced using the Sanger method.
Results Twenty-five single-nucleotide polymorphisms (SNPs) were identified in theMTND4 gene. The genotype frequencies of
the study population showed a statistically significant association between rs2853495 G>A (Gly320Gly) and male infertility (P =
0.0351). Similarly, the allele frequency test showed that rs2853495 G>A (Gly320Gly) and rs869096886 A>G (Leu164Leu) were
significantly associated with male infertility (adjusted OR = 2.616, 95% CI = 1.374–4.983, P = 0.002; adjusted OR = 2.237, 95%
CI = 1.245–4.017, P = 0.007, respectively).
Conclusion In conclusion, our findings suggested that male infertility was correlated with rs2853495 and rs869096886 SNPs in
MTND4.
Keywords mtDNA .MTND4 . SNP .Male infertility
Introduction
Infertility, the inability to conceive after 12 months of unprotect-
ed sexual intercourse, affects 2.5–15% of couples in the world
[1]. Approximately 50% of infertility cases are caused by male
factors [2]. Sperm motility is an essential process for sperm
movement to the fertilization site and normal fertilization which
demand energy produced by sperm mitochondria [3].
Mitochondrial genes play an important role in the mature sperm
construction and flagella movement after ejaculation [4].
Moreover, mitochondria, the powerhouse of the cell [5],
have their own genome that encodes 13 proteins [6]. The
human mitochondrial genome is considerably compact and
circular consisting of 16,569 bp. The rate of mutations in the
mitochondrial DNA (mtDNA) is high due to the lack of his-
tones and DNA repair mechanisms [7]. Therefore, mutations
that occur in the mitochondrial genome play a major role in
some human genetic disorders [8]. It has been reported that
mutations in the mtDNA are associated with certain types of
male infertility. For instance, mutations in the mtDNA poly-
merase (POLG) locus were associated with male infertility
[9]. In another study, a high incidence of single-nucleotide
polymorphisms (SNPs) in mtDNA was observed in semen
samples of poor sperm quality [10]. Moreover, several studies
have shown that mtDNA mutations in sperm can lead to re-
duced sperm motility and eventually to male infertility
[10–12]. However, mtDNA mutations especially reduce
sperm motility without significantly compromising the fertil-
ity of young males [13].
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Oxidative phosphorylation (OXPHOS) is an effective way
to release energy; however, it also generates reactive oxygen
species (ROS) during mitochondrial activity. Large amounts
of ROS are detrimental to cells [14]. The generation of reac-
tive oxygen species occurs as a natural physiological process
in sperm. However, a small amount of ROS is actually re-
quired for normal sperm functioning. ROS such as nitric oxide
(NO) and superoxide anion play an important role in the ca-
pacitation and the acrosome reaction. Moreover, ROS are in-
volved in sperm-oocyte communication, but disproportionate
levels of ROS production can negatively impact the sperma-
tozoa quality and impair their fertilization capacity [15].
Several studies showed a strong correlation between im-
paired mtDNA and the occurrence of male infertility condi-
tions such as asthenozoospermia, oligozoospermia, and tera-
tozoospermia. For instance, large-scale deletions in the
mtDNA have been identified in asthenozoospermia in various
populations [16–18], while other studies established an asso-
ciation between CAG repeats and the development of oligo-
zoospermia and teratozoospermia in infertile males [19].
Moreover, the removal of certain structural genes and
tRNA genes may result in a large number of mtDNA dele-
tions. Sperm containing defective mitochondria cannot effec-
tively produce adenosine triphosphate (ATP) and are more
likely to produce ROS and free radicals, thereby causing de-
fects in mtDNA, producing less energy, and leading to deficits
in motility and fertility [11, 20].
Genetic disorders are responsible for about 15–30%
of male factor infertility. The proper understanding of
the genetic basis of reproductive problems is requisite to
managing the treatment of an infertile couple [21, 22].
Genetic disorders involving male infertility may be
caused by chromosomal abnormalities, autosomal gene
defects, or Y chromosome mutations.
The karyotype variant of Klinefelter’s syndrome,
47,XXY, is the most common numerical chromosomal
abnormality associated with male infertility and occurs
in 1 in 500 newborn males [23, 24]. Eleven percent of
azoospermic and 0.7% of oligozoospermic males are
probable to have this condition [24].
The human Y chromosome has also been found to be re-
sponsible for male infertility. Y-linked mutations have the
greatest impact on spermatogenesis [23, 25]. Y-chromosome
microdeletions have been reported in patients with suboptimal
semen quality (7.4%) [26].
Sperms with defective mitochondria cannot effectively
produce the required ATP and are more likely to produce free
radicals/reactive oxygen species, causing genotoxicity and re-
duced sperm motility which can lead to male infertility [11,
20]. On the other hand, the mitochondrial respiratory chain
consists of 13 proteins which are a constitutional part of mem-
brane complexes. In particular, complex I includes seven nic-
otinamide adenine dinucleotide hydride (NADH)
dehydrogenase subunits (ND1, ND2, ND3, ND4, ND4L,
ND5, and ND6). In comparison, complex III contains cyto-
chrome B, complex IV contains three subunits: cytochrome
oxidase subunit I (COX-I), cytochrome oxidase subunit II
(COX-II), and cytochrome oxidase subunit III (COX-III),
and complex V contains ATPase 6 and ATPase 8 [27].
Complex I, the first enzyme of the electron transport chain,
oxidizes NADHwhich is generated through the Krebs cycle in
the matrix of mitochondria. Therefore, complex I is the main
entry point for electrons to the respiratory chain and is sug-
gested as the rate-limiting step in overall respiration [28].
MTND4 gene spans from 10,760 to 12,137 in the human
mtDNA genome (National Centre of Biotechnology
Information; NCBI). MTND4 is one of the core
mitochondrial-encoded subunits of the mitochondrial
membrane respiratory chain NADH dehydrogenase
(Complex I) [29, 30]. MTND4 gene codes for the
NADH-ubiquinone oxidoreductase chain 4 (ND4) pro-
tein [31]. The ND4 protein is located in the mitochon-
drial inner membrane and is the largest of the five com-
plexes of the electron transport chain [32]. MTND4
plays an important role in the oxidative phosphorylation
process and it has been reported to be associated with
sperm motility [10, 11, 33]. Various studies have shown
a significant association of polymorphisms in MTND4
with age-related muscular degeneration (AMD), Leber’s
hereditary optic neuropathy (LHON), mesial temporal
lobe epilepsy (MTLE), and cystic fibrosis [31],
[34–36]. However, the overall association between
MTND4 polymorphisms and male infertility remains
unknown.
Accordingly, we aimed to examine whetherMTND4 poly-
morphisms contribute to male infertility. We first identified
SNPs in the MTND4 gene by Sanger sequencing and then




One hundred and twelve semen samples were collected from
subfertile and fertile males attending the in vitro fertilization
clinic. The informed consent of all individuals was obtained
before collecting samples. The study population aged between
26 and 48 years had been divided into two groups according to
semen analysis results [37] to 68 subfertile and 44 fertile
males. The individuals with age over 50 years old, men ex-
posed to chemotherapy or radiotherapy, varicocele or any sur-
gical procedure in the reproductive tract, diabetes, blood pres-
sure and any chronic disease, hormonal imbalance, or Y chro-
mosome microdeletion were excluded from this study.
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Mitochondrial DNA extraction
Before DNA extraction, semen samples were purified by
discontinuous pure sperm gradient (45% and 90%) tech-
nique (Nidacon International, Sweden). Briefly, semen
samples were loaded at the upper level of the gradient
and centrifuged at 250g for 20 min. Thereafter, the pel-
let was collected and washed twice with a sperm wash-
ing medium. The absence of all other cells was con-
firmed by microscopic examination.
The whole genome was extracted from the spermatozoa
using a QIAamp DNA Mini Kit; then, the mitochondrial
DNA was amplified by using the REPLI-g Mitochondrial
DNA Kit (QIAGEN, Hilden, Germany), as recommended
by the kit instruction manual. Isolated DNA with an optimal
density ratio of 260/280 of 1.8 or more was chosen for further
analysis and stored at − 80 °C.
Polymerase chain reaction
The polymerase chain reaction was applied to determine the
gene variant by using self-designed pairs of specific primers
using PRIME 3 software for the target gene (MTND4) (Nd4.F
5′-CTACGTACATAACCTAAACC-3′, Nd4.R 5′-CTGA
TGTTTTGGTTAAAC-3′ (Tm = 49 °C)), where the amplicon
size is 1432 bp. An additional internal primer Nd4.I: 5′-CTTA
AAACTAGGCGGCTATGG-3′ was designed for sequenc-
ing. The primers were based on the human mitochondrial
sequence; accession number NC_012920, provided by the
National Centre of Biotechnology Information and ordered
from Microsynth seq lab-Germany.
The amplification reaction was carried out in a 30 μL
mixture using ThermoScientific Dream Taq Green PCR
master mix (2×), according to manufacturer instructions.
To confirm the presence of an amplified PCR product,
5 μL of each PCR sample was investigated by 1%
agarose gel electrophoresis using 1× TBE buffer and a
DNA ladder (1 kb) (NE Biolabs, USA) as a reference.
Electrophoresis was carried out at 100 V for 45 min.
Gels were stained with red-safe stain and then DNA
was visualized by ultra-violet (UV) transilluminator with
Image LabTM Software (BIO-RAD, USA) (Fig. 1).
DNA sequencing
Samples were purified and sequenced by the Sanger
method at Microsynth Seq lab in Germany. The SNPs
of MTND4 were detected by sequence analysis based on
the reference sequence of human MT (GenBank acces-
sion number: NC_012920). The sequenced DNA sam-
ples were analyzed using Mutation Surveyor software to
determine the mt-DNA variants.
Statistical analyses
Genotypes and allele frequencies between the subfertile
(case) and fertile (control) groups were performed using
the chi-square test and Fischer’s exact test, respectively.
The identified SNPs were also tested for the Hardy-
Weinberg equilibrium test to determine the genotype
frequencies and to describe statistically significant devi-
ations from the equilibrium. The allele frequencies be-
tween the subfertile (case) and fertile (control) groups
were measured according to odds ratios (ORs) and 95%
confidence intervals (CIs). P value was considered sta-
tistically significant if ≤ 0.05. Statistical analyses were
performed using the SPSS Version 22 for Mac.
Results
In this study, males who had one child or more and had
normal semen parameters [volume: 1.5 ml, sperm count:
15 million spermatozoa/ml; normal forms: 4%; vitality:
58% live; progressive motility: 32%; total (progressive
+ nonprogressive) motility: 40%, according to WHO
guideline 2010] were considered as the fertile group,
and those who failed to have children after 12 months
or more of regular unprotected sexual intercourse and
had one sperm parameters under WHO (2010) criteria
were considered as the sub-fertile group. Thus, subjects
were divided into two groups: a control group (fertile, n
= 44) and a case group (subfertile, n = 68).
The study population did not show any significant
difference between the ages of the subfertile and fertile
group (P = 0.247). On the other hand, the semen anal-
ysis showed significant differences in the mean percent-
age of sperm concentration, total motility, and morpho-
logically normal spermatozoa between the fertile and
subfertile individuals (P < 0.0001) (Table 1).
Fig. 1 Representative gel electrophoresis on 1% agarose gel of PCR
products for the amplification of the MTND4 gene (1432 Bp). Lane M:
DNA ladder (100–10,000 bp) (NE Biolabs, USA), lanes 1-18: PCR
sample products, lane -ve: negative control. Electrophoresis was carried
out at 100 V for 45 min. Gels were stained with red-safe stain and then
DNA was visualized by ultra-violet (UV) transilluminator using Image
LabTM Software (BIO-RAD, USA)
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Genotypes and allelic frequencies
A total of twenty-five SNPs inMTND4 in the case and control
groups were detected: rs2853495, rs2857284, rs2853496,
rs2853497, rs3087901, rs2853493, rs2853490, rs3088053,
rs2853491, rs2857285, rs28358282, rs28594904,
rs28669780, rs28415973, rs28471078, rs55714831,
rs28358283, rs75214962, rs28529320, rs2853494,
rs28609979, rs28358286, rs28359168, rs28384199, and
rs869096886 (Table 2).
To determine whether the variations ofMTND4were relat-
ed to infertility, we compared each of the genotypes and allele
frequencies between the case and control groups. For the
rs2853495, the mutant allele was higher than the wild-type
allele frequency (P = 0.002) (Table 3) and the number of
homozygous mutant types (AA) was higher than the homozy-
gous wild type (GG) (P = 0.0351). Furthermore, the wild-type
allele frequency in rs869096886 was significantly higher than
the mutant allele frequency (P = 0.007). The remaining SNPs
showed no significant difference in allele and genotype distri-
bution among fertile and subfertile groups. Moreover, all
SNPs were tested for the Hardy-Weinberg genotype frequen-
cy test. All of these SNPs showed a significant deviation from
HWE (P < 0.0001).
Discussion
Sperm mitochondrial DNA contains no introns and lacks the
protection of histones or DNA binding proteins. Therefore, it
replicates rapidly without DNA repair mechanisms [6].
Consequently, mitochondrial mutation rates are higher by
about 10–100 times than nuclear DNA. Mutations that occur
in the mitochondrial genome play a major role in some human
genetic disorders [8].
The purpose of the current study was to investigate whether
polymorphisms in the MTND4 gene are correlated with male
infertility. Several studies have reported that among the iden-
tifiedMTND4 SNPs, rs2853495 is related to ulcerative colitis
and pancreatic cancer [38, 39], and rs869096886 is related to
schizophrenia [40], whereas rs2857285 is associated with a
more invasive form of ovarian cancer [41]. Moreover,
rs28384199 is related to late-onset encephalopathy and is con-
sidered a highly pathogenic mutation [42].
Additionally, many males with ulcerative colitis, a princi-
pal form of inflammatory bowel disease, are unable to control
their smoking, drinking, and eating habits, which can contrib-
ute to sexual dysfunction and infertility [43]. Moreover, it has
been repeatedly reported that the fertility of schizophrenia
patients is lower than that of people with other psychiatric
illnesses and the general population [44].
In the present study, we scanned the polymorphisms
of subfertile and fertile males by direct sequencing of
the MTND4 gene, and identified twenty-five SNPs as
follows: rs2853495, rs2857284, rs2853496, rs2853497,
rs3087901, rs2853493, rs2853490, rs3088053,
rs2853491, rs2857285, rs28358282, rs28594904,
rs28669780, rs28415973, rs28471078, rs55714831,
rs28358283, rs75214962, rs28529320, rs2853494,
rs28609979, rs28358286, rs28359168, rs28384199, and
rs869096886. The rs28594904 (Ser86Asn or Ser86Thr),
rs28669780 (Leu282Met), and rs28384199 (Arg340Ser
or Arg340Gly) SNPs are missense variants, whereas
the rest of SNPs are synonymous coding variants. All
SNPs were also tested for the Hardy-Weinberg genotype
frequency test (HWE). All of the SNPs showed a sig-
nificant deviation from HWE (P < 0.0001) which means
that the genotype distribution was not following Hardy-
Weinberg and biased to one group.
Overall, in the genotype frequency test, we found a signif-
icant association between the SNP rs2853495 and male infer-
tility. In the allele frequency test, rs2853495 (G11719A) and
rs869096886 (A11251G) were also associated with male in-
fertility, indicating that the presence of the allele itself may be
associated with male infertility regardless of its genotype.
Moreover, the OR of rs2853495 SNP was associated
with a 2.61 times increased risk of subfertile males than
fertile ones. Furthermore, the OR of rs869096886
(2.237) was also higher for subfertile males than for
control. These results demonstrated that although the
rs2853495 and the rs869096886 SNPs are synonymous
variants and do not cause an amino acid change, they
can be related to male infertility. Nevertheless, synony-
mous variants have been suggested to play a role in
gene regulation and possibly the development of
Table 1 Comparison of the
semen analysis parameters
between the fertile and subfertile
groups
Parameter Fertile (n = 44)
Median (range)
Subfertile (n = 68)
Median (range)
P value
Age 34 (26–48) 34 (26–48) 0.247
Sperm concentration (106 × 1ml) 78.5 (17–185) 28 (0.6–135) <0.0001
Total motility (PR + NP%) 67.5 (44–90) 48.5 (2–88) < 0.0001
Morphologically normal spermatozoa (%) 24.5 (20–30) 15 (0–28) < 0.0001
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Table 2 Genotype frequency of MTND4 polymorphisms between subfertile and fertile groups
SNP Contig position Protein position Genotype Subfertile (N) Fertile (N) P value
rs2853495
G>A

















































































































11947 Thr396Thr AA 68 43 0.211
AG 0 0
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Table 2 (continued)















The significant results are in bold
Table 3 Allele frequency of MTND4 polymorphisms between subfertile and fertile groups
SNP Contig position Protein position Allele Subfertile (N) Fertile (N) OR (95% CI)* P value
rs2853495
G>A
































11335 Asn192Asn C 132 84 1.571 (0.382–6.456) 0.714
T 4 4
rs2857285 T>C,G 10915 Cys52Cys T 132 87 0.379 (0.041–3.453) 0.650
C 4 1
rs28358282 T>C 10810 Leu17Leu T 135 85 4.765 (0.487–46.58) 0.302
C 1 3
rs28594904 G>A,C 11016 Ser86Asn
Ser86Thr
G 134 85 2.365 (0.386–14.45) 0.383
A 2 3








11722 Leu321Leu T 134 86 1.558 (0.215–11.27) 0.646
C 2 2
rs55714831 C>T 11332 Ala191Ala C 135 87 1.552 (0.095–25.15) 1.000
T 1 1
rs28358283 A>G 10819 Lys20Lys A 134 88 0.304 (0.014–6.411) 0.520
G 2 0








11641 Met294Met A 136 86 7.890 (0.37–166.44) 0.153
G 0 2














C 134 88 0.304 (0.01–6.41) 0.520
G 2 0
rs869096886 A>G 11251 Leu164Leu A 105 53 2.237 (1.24–4.01) 0.007
G 31 35
SNP single-nucleotide polymorphism, OR odds ratio, CI confidence interval
The significant results are in bold
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diseases [45]. For instance, synonymous mutations have
been reported to regulate gene expression through the
miRNA [46]. In another example, a synonymous muta-
tion was found to affect mRNA stabili ty [47].
Therefore, these synonymous variants in the mtDNA
need to be investigated by functional studies to reveal
their possible role in sperm function and male infertility.
Additionally, mtDNA methylation has been related to
sperm quality which can be associated with the synon-
ymous mutations [48]. The rs2853495 SNP is a synon-
ymous variant, as the codon substitution from [GGG] to
[GGA] at position 11719 does not change the encoded
amino acid (glycine). Additionally, the rs869096886 is
also a synonymous variant that is changed from [CTA]
to [CTG] at position 11251. Therefore, the amino acid
remains leucine which means that this change does not
affect the resulting product’s protein sequence (NCBI).
Additionally, the copy number variant (CNV) is pro-
posed to play a role in the development of certain dis-
eases such as autism [49]. However, CNV will be more
powerful when it is combined with other SNPs. Variants
of unknown significance (VOUS) are another area that
can be further investigated to correlate certain diseases
and disorders with the genetic makeup of certain indi-
viduals. Genetic markers require intensive functional
studies to reveal the molecular role of specific variants
in the development of disease.
Less is known about mitochondrial gene polymor-
phisms in male infertility. Therefore, we identified the
genetic associations between mitochondrial polymor-
phisms and male infertility. Our study is the first to
explore the association between MTND4 SNPs and male
infertility. Although the sample size was small, our
findings suggest that the rs2853495 and rs869096886
SNPs in MTND4 might be associated with male infer-
tility. However, analysis of a larger sample is needed
and will allow a better understanding and clarification
of the role of these MTND4 SNPs in male infertility.
Conclusion
In conclusion, we identified an as yet unknown associ-
ation between mitochondrial gene polymorphisms in
MTND4 and male infertility. In the genotype frequency
test, we found a significant association between the SNP
rs2853495 and male infertility. In the allele frequency
test, rs2853495 and rs869096886 were also associated
with male infertility. This indicates that mitochondrial
genetics might help to give a better understanding of
the correlation between the presence of these SNPs
and the male’s infertility. Moreover, larger prospective
studies are required to confirm these associations of
mitochondrial gene polymorphisms and male infertility
and to clarify the definite effect of the mitochondrial
genetic variations in male infertility.
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